 | Up a level |
Lee, Yoomi, Urbanska, Aleksandra M, Hayakawa, Yoku, Wang, Hongshan, Au, Andrew S, Luna, Aesis M, Chang, Wenju, Jin, Guangchun, Bhagat, Govind, Abrams, Julian A et al (show 8 more authors)
(2017)
Gastrin stimulates a cholecystokinin-2-receptor-expressing cardia progenitor cell and promotes progression of Barrett's-like esophagus.
ONCOTARGET, 8 (1).
pp. 203-214.
Lloyd, Katie A 
ORCID: 0000-0002-2325-8050, Moore, Andrew R, Parsons, Bryony N ORCID: 0000-0003-3599-1089, O'Hara, Adrian ORCID: 0000-0003-1837-680X, Boyce, Malcolm, Dockray, Graham J, Varro, Andrea and Pritchard, D Mark ORCID: 0000-0001-7971-3561
(2016)
Gastrin-induced miR-222 promotes gastric tumor development by suppressing p27(kip1).
ONCOTARGET, 7 (29).
pp. 45462-45478.
Lloyd, Katie A, Parsons, Bryony N ORCID: 0000-0003-3599-1089, Burkitt, Michael D, Moore, Andrew R, Papoutsopoulou, Stamatia ORCID: 0000-0001-6665-8508, Boyce, Malcolm, Duckworth, Carrie A ORCID: 0000-0001-9992-7540, Exarchou, Klaire, Howes, Nathan, Rainbow, Lucille ORCID: 0000-0003-0447-6885 et al (show 6 more authors)
(2020)
Netazepide Inhibits Expression of Pappalysin 2 in Type 1 Gastric Neuroendocrine Tumors.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 10 (1).
pp. 113-132.
Boyce, Malcolm, Moore, Andrew R, Sagatun, Liv, Parsons, Bryony N ORCID: 0000-0003-3599-1089, Varro, Andrea, Campbell, Fiona, Fossmark, Reidar, Waldum, Helge L and Pritchard, D Mark ORCID: 0000-0001-7971-3561
(2017)
Netazepide, a gastrin/cholecystokinin-2 receptor antagonist, can eradicate gastric neuroendocrine tumours in patients with autoimmune chronic atrophic gastritis.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 83 (3).
466 - 475.
Boyce, Malcolm, Lloyd, Katie A ORCID: 0000-0002-2325-8050 and Pritchard, D Mark ORCID: 0000-0001-7971-3561
(2016)
Potential clinical indications for a CCK<sub>2</sub> receptor antagonist.
CURRENT OPINION IN PHARMACOLOGY, 31.
pp. 68-75.